世界卫生组织与非洲药品管理局在基加利首届机构周推进监管合作
正文 · 中文译文
世界卫生组织(WHO)在首届非洲药品管理局(AMA)周暨第十一届非洲药品监管机构会议(AMRC)上重申了其加强非洲监管体系的承诺,该会议于2026年10月25日至30日在卢旺达基加利举行。此次会议汇聚了非洲监管机构、政策制定者、产业界和国际伙伴,标志着将非洲大陆监管雄心转化为协调行动以改善安全、有效和高质量保证的医疗产品可及性的重要里程碑。 在一段视频致辞中,WHO总干事谭德塞博士强调了整个非洲大陆取得的进展,指出目前已有10个非洲国家监管机构在WHO全球基准评估中达到成熟度等级3,表明它们已建立起稳定、运作良好且整合的监管体系。他重申了WHO支持AMA和国家监管机构的承诺,同时呼吁持续的政治和财政投入以及更广泛的AMA条约批准。 此次会议的一大亮点是AMA七个技术委员会的成立,这些委员会将在关键监管职能领域提供独立的科学专业知识,包括药品和疫苗评估、临床试验监督、检查、警戒和医疗器械。这些委员会代表着在加强非洲各国基于科学的决策、监管依赖和工作共享方面迈出的重要一步。 本周还启动了非洲药品管理局(AMA)的监管创新与生产准备中心以及能力强化中心,旨在支持本地药品生产、提供早期科学建议并增强整个非洲大陆的监管专业知识。 世界卫生组织(WHO)与非洲药品管理局共同召集了第十一届非洲药品监管者会议(AMRC),提供了一个推进监管协调、趋同和互认的平台,同时强化国家监管机构在构建具有韧性的非洲大陆监管生态系统中的核心作用。 世界卫生组织监管与安全单位负责人兼监管与预认证部代理主任Hiiti Sillo代表世卫组织出席活动,他强调强大的国家监管机构是非洲药品管理局成功的基础。他着重指出投资非洲监管专业知识、加强监管机构之间的信任以及确保监管合作带来切实公共卫生效益的重要性。 讨论建立在世卫组织与非洲药品管理局于2026年5月签署的合作框架协议以及随后的五年联合运营计划基础之上。这些共同为协调行动奠定了基础,以加强监管能力、改善安全监测、应对劣质和伪造医疗产品,并支持创新和本地生产。 随着非洲药品管理局推进其投入运作,世卫组织将继续通过技术专长、国际公认标准和能力发展来支持非洲主导的监管解决方案。 更强大的国家监管机构通过协调一致的全大陆监管生态系统开展合作,对于确保及时获得安全、有效且质量有保证的医疗产品至关重要,从而保护公众健康、加强卫生安全并推进非洲各地的全民健康覆盖。
正文 · 英文原文
The World Health Organization (WHO) reaffirmed its commitment to strengthening Africa's regulatory systems during the inaugural African Medicines Agency (AMA) Week and the 11th African Medicines Regulators Conference (AMRC), held from 25 to 30 October 2026 in Kigali, Rwanda. Bringing together African regulators, policy-makers, industry and international partners, the event marked an important milestone in translating continental regulatory ambitions into coordinated action to improve access to safe, effective and quality-assured medical products. In a video message, WHO Director-General Dr Tedros Adhanom Ghebreyesus highlighted the progress made across the continent, noting that 10 African national regulatory authorities have now reached Maturity Level 3 under WHO's Global Benchmarking, demonstrating that they have established stable, well-functioning and integrated regulatory systems. He reaffirmed WHO's commitment to supporting both AMA and national regulators, while calling for sustained political and financial investment and broader ratification of the AMA Treaty. A major highlight of the event was the inauguration of AMA's seven technical committees, which will provide independent scientific expertise across key regulatory functions, including medicines and vaccines evaluation, clinical trials oversight, inspections, vigilance and medical devices. The committees represent a significant step towards strengthening science-based decision-making, regulatory reliance and work-sharing across African countries. The week also saw the launch of AMA's Regulatory Innovation and Manufacturing Readiness Hub and Capacity Strengthening Hub, designed to support local pharmaceutical manufacturing, provide early scientific advice and strengthen regulatory expertise across the continent. WHO co-convened the 11th African Medicines Regulators Conference (AMRC) with AMA, providing a platform to advance regulatory harmonization, convergence and reliance, while reinforcing the central role of national regulatory authorities in building a resilient continental regulatory ecosystem. Representing WHO at the event, Hiiti Sillo, WHO's Head of Regulation and Safety Unit and Acting Director of Regulation and Prequalification Department, emphasized that strong national regulatory authorities are the foundation of a successful AMA. He underscored the importance of investing in African regulatory expertise, strengthening trust between authorities and ensuring that regulatory cooperation delivers tangible public health benefits. The discussions built on the Framework Agreement for Collaboration signed by WHO and AMA in May 2026, and the subsequent five-year joint operational plan. Together, these provide a foundation for coordinated action to strengthen regulatory capacity, improve safety surveillance, address substandard and falsified medical products, and support innovation and local manufacturing. As AMA advances its operationalization, WHO will continue supporting African-led regulatory solutions through technical expertise, internationally recognized standards and capacity development. Stronger national regulatory authorities, working together through a harmonized continental regulatory ecosystem, are essential to ensuring timely access to safe, effective and quality-assured medical products, thereby protecting public health, strengthening health security and advancing universal health coverage across Africa.